7:26 PM · 21 March 2025

BREAKING: Boeing surges 5% as company wins next-generation US jet fighter program; Lockheed Martin down 5%

Boeing
Stocks
BA.US, Boeing Co
-
-
Lockheed Martin
Stocks
LMT.US, Lockheed Martin Corp
-
-

Boeing (BA.US) shares surged more than 5% after the company won a strategic Pentagon contract for a new U.S. fighter jet, valued at $20 billion. Lockheed Martin (LMT.US) shares plunged nearly 5% following the news, as the company failed to outcompete Boeing. Recently, Boeing’s CFO signaled that the company’s cash burn rate is slowing this year by 'hundreds of millions of dollars'." After the news Boeing shares has jumped above both EMA200 and EMA50 averages, signalling the potential trend reversal.

 
 
 

Source: xStation5

 

Source: xStation5

Source: xStation5

15 October 2025, 8:10 PM

TSMC Earnings Preview: Will the Key Semiconductor Supplier Surprise the Market?

15 October 2025, 6:05 PM

US Open: American Indices Rally on Anticipated End of Fed Balance Sheet Reduction

15 October 2025, 5:53 PM

Bank of America, Wells Fargo, and Morgan Stanley: Q3 2025 Earnings Overview

15 October 2025, 4:24 PM

Abbott reports no surprises in Q3, but tariff risks and lowered forecasts drag the share price down💡

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 1 700 000 investors from around the world